INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

Historical Holders from Q1 2016 to Q3 2025

Symbol
PJP
Type / Class
Equity / PHARMACEUTICALS
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
638,030
Holdings value
$59,014,644
% of all portfolios
0.001%
Number of holders
93
Number of buys
27
Number of sells
-29
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 638,030 $59,014,644 +$125,900 $92.49 93
2025 Q2 648,304 $51,793,796 -$4,348,337 $79.87 92
2025 Q1 686,556 $59,329,046 -$7,420,789 $86.61 96
2024 Q4 771,959 $63,800,712 +$984,893 $82.62 93
2024 Q3 759,068 $65,987,834 -$1,444,326 $86.97 97
2024 Q2 772,678 $63,597,132 -$4,040,264 $82.21 89
2024 Q1 850,599 $66,020,158 +$10,912,907 $80.16 93
2023 Q4 690,752 $52,571,098 -$3,529,113 $76.1 86
2023 Q3 718,716 $52,012,966 -$4,223,551 $72.37 82
2023 Q2 770,569 $58,279,520 -$7,369,268 $75.62 84
2023 Q1 864,587 $65,706,224 -$7,112,845 $76 86
2022 Q4 960,831 $75,515,897 +$1,189,802 $78.6 92
2022 Q3 968,120 $69,031,328 +$13,740,443 $71.3 79
2022 Q2 774,936 $58,099,507 +$1,531,676 $74.97 77
2022 Q1 750,950 $59,765,049 -$3,608,649 $79.59 83
2021 Q4 797,603 $64,683,241 -$11,337,748 $81.13 78
2021 Q3 943,943 $73,105,100 +$8,871,294 $77.37 92
2021 Q2 828,585 $66,678,384 -$232,033 $80.45 88
2021 Q1 831,812 $65,599,188 -$16,638,970 $78.88 86
2020 Q4 1,051,101 $75,081,504 -$5,092,016 $71.39 85
2020 Q3 1,129,485 $72,171,244 -$15,663,262 $63.87 83
2020 Q2 1,386,375 $89,733,993 +$423,042 $64.72 85
2020 Q1 1,371,396 $75,501,624 -$9,823,991 $55.01 84
2019 Q4 1,555,221 $100,644,541 -$34,607,398 $64.72 94
2019 Q3 2,050,980 $116,238,583 +$34,497,474 $56.66 81
2019 Q2 1,432,968 $86,206,047 +$22,441,438 $60.16 80
2019 Q1 1,045,167 $68,093,369 -$15,449,049 $65.17 90
2018 Q4 1,286,629 $80,277,439 -$4,463,456 $62.35 88
2018 Q3 1,347,135 $98,959,347 +$13,536,254 $73.49 86
2018 Q2 1,178,051 $79,262,795 +$79,257,889 $67.21 77
2018 Q1 73 $4,555 $62.4 1
2017 Q4 73 $4,684 +$4,684 $64.16 1
2016 Q2 0 $0 -$7,000 0
2016 Q1 100 $7,000 $70 1